University of PennsylvaniaPhiladelpiha, Pennsylvania, United States
Disclosure information not submitted.
ORF28-06 - Efficacy and Safety of Once-Daily Oral Paltusotine in Patients with Acromegaly: Up to 2 Years in the PATHFNDR-1 and PATHFNDR-2 Open-Label Extension Studies
Sunday, June 14, 20262:30 PM - 2:45 PM CT